Ep.27 – Molnupiravir – Finally, an Oral Option for Outpatients with COVID-19

This episode features Dr. Travis Jones from DASON. Details regarding the FDA meeting on molnupiravir are available here: https://www.fda.gov/advisory-committees/advisory-committee-calendar/november-30-2021-antimicrobial-drugs-advisory-committee-meeting-announcement-11302021-11302021.

For more information about DASON, please visit: https://dason.medicine.duke.edu.